Article Text

Download PDFPDF
Use of buccal midazolam in children
  1. N Hussain1,
  2. E Regan1,
  3. J Gosalakkal1,
  4. W P Whitehouse2
  1. 1Leicester Royal Infirmary, Leicester, UK
  2. 2School of Human Development, University of Nottingham, Nottingham, UK
  1. Correspondence to:
    Dr Nahin Hussain
    Paediatric Neurology, Leicester Royal Infirmary, University of Leicester NHS Trust, Leicester LE1 5WW, UK; dr_nahin{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with much interest the recent letter on buccal midazolam by Hindley and Jameson.1

The main reason that some recommend a buccal midazolam test dose is concern about the risk of an adverse reaction, particularly respiratory depression or apnoea, especially should it occur outside hospital. However, there is evidence that buccal midazolam is more effective than rectal diazepam and is not associated with an increased incidence of respiratory depression.2

We recently undertook a survey of epilepsy nurse specialists. Thirty questionnaires were sent to …

View Full Text


  • Competing interests: None declared.